Novartis | NVS - Kreditur Perdagangan





Kreditur Perdagangan Perubahan Tanggal
AbbVie USD 33.3B 29.71B 2026-06
Amgen USD 20.83B 17.97B 2026-09
AstraZeneca USD 23.57B 679M 2026-09
Bausch Health Companies USD 517M 76M 2026-09
Biogen USD 430.3M 26.4M 2026-09
Bristol-Myers Squibb USD 4.63B 470M 2026-09
Canopy Growth CAD 28.61M 6.21M 2026-06
Corcept Therapeutics USD 21.92M 7.01M 2026-09
Drreddys Laboratories INR 36.08B 13.72B 2026-09
Eli Lilly USD 5.79B 319M 2026-09
Gilead Sciences USD 934M 260M 2026-09
GlaxoSmithKline GBP 15.63B 1.29B 2026-09
Glaxosmithkline GBP 15.63B 1.3B 2026-09
J&J USD 9.32B 94M 2026-09
Merck USD 5.03B 1.2B 2026-09
Novartis USD 4.24B 15M 2026-09
Novartis USD 4.24B 79M 2026-09
Pacira USD 17.5M 4K 2026-09
Perrigo USD 390.5M 9.9M 2026-09
Pfizer USD 4.07B 511M 2026-09
Phibro Animal Health USD 136.45M 9.13M 2026-09
Prestige Brands USD 44.02M 7.17M 2026-09
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 24.55B 957M 2026-09
Sanofi EUR 23.6B 888M 2026-06
Supernus Pharmaceuticals USD 8.52M 2.92M 2026-09
Zoetis USD 419M 33M 2026-09